BiotechTube
Home/Pipeline/Exelya®

Exelya®

Not Specified

PipelineTechnology Asset

Key Facts

Indication
Not Specified
Phase
Pipeline
Status
Technology Asset
Company
APR Applied Pharma Research

About APR Applied Pharma Research

APR Applied Pharma Research is a mission-driven Swiss pharma company focused on improving the lives of patients with rare diseases through innovative, patent-protected products. The company has successfully built a portfolio of marketed products, including PKU GOLIKE® and Nexodyn®, and maintains a promising clinical pipeline. Its strategy integrates direct commercialization in key European markets with a global partner network and a complementary CDMO services division, creating a diversified and resilient business.

View full company profile

Therapeutic Areas

Inherited Metabolic DisordersRare Dermatological DiseasesAdvanced Wound CareCancer Supportive CareOcular Diseases

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved